Want to create an interactive transcript for this episode?
Podcast: CME
Episode: Pulmonary Hypertension: Diagnosis, Management, and Updates – Chairperson’s Perspective
Description:
Host: Vallerie V. McLaughlin, MD
During a satellite symposium at the AHA 2024 Annual Meeting, experts reviewed the role of novel disease-modifying therapies (DMTs) in treating and managing pulmonary hypertension (PH) and the impact of current PH treatments vs novel DMTs. They also discussed how to identify appropriate patients for DMTs and strategies to customize treatment with risk-based assessments. In addition, highlights from the 7th World Symposium in PH were discussed. Tune in to keep up!